A unit of CSPC Pharmaceutical Group is moving ahead with a planned share listing in Hong Kong, securing approval from its board for the offering as China's biotech sector heats up. CSPC Innovation, a ...

In the second quarter, Tealwood Asset Management Inc. expanded its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by ...

As U.S. pharma braces for a $236B patent cliff, Chinese biotech surges—and EquitiesFirst unlocks capital with equity-backed ...

Alexandria Real Estate Equities is rated a 'Buy' for its undervalued price, high 6.3% yield, and strong long-term prospects.

Biotech company Genmab announced Sept. 29 it entered into an agreement to acquire all shares of Merus. The all-cash ...

Star hopes its drug, which is currently in late-stage testing, might prove a more convenient, longer-lasting alternative to ...

Angel Yeast (SH600298), a global leader in yeast and biotechnology, today announced that its subsidiary Xizang Angel Zhufeng ...

With a strong profitability outlook, Eli Lilly and Company (NYSE:LLY) secures a spot on our list of the 14 Stocks That Will ...

Despite its status as an emerging tech market, the Triangle is no longer chasing Silicon Valley; it’s competing with it.

Scientists, researchers, engineers, industry leaders and innovators gather for UK's must-attend industry event ...

Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...